XML 18 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (Deficit) (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 17, 2019
Feb. 25, 2019
Jan. 02, 2019
Jan. 02, 2017
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2016
Dec. 31, 2017
Stock options outstanding         3,972,866   3,972,866   3,846,299   3,566,299
Stock options outstanding weighted average exercise price         $ 1.36   $ 1.36   $ 1.36   $ 1.33
Stock options intrinsic value         $ 168,572   $ 168,572        
Number of stock options granted             126,567   280,000    
Stock option weighted average exercise price per share             $ 1.15   $ 1.75    
Compensation expense             $ 850,767 $ 868,933      
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized         668,190   $ 668,190        
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition             2 years 10 months 14 days        
Stock options granted, term             7 years 2 months 12 days   8 years 18 days    
Number of stock options vested             544,187   972,651    
Debt instrument, face amount         665,000   $ 665,000        
Accrued interest         $ 35,000   $ 35,000        
Class of warrant or right, outstanding         3,826,658   3,826,658        
Class of warrant or right, outstanding, weighted average exercise price         $ 1.05   $ 1.05        
Class of warrant or right, outstanding, intrinsic value         $ 3,633,335   $ 3,633,335        
Predecessor Warrants [Member]                      
Class of warrant or right, number of securities called by warrants or rights         295,945   295,945        
Class of warrant or right, exercise price of warrants or rights         $ 1.25   $ 1.25        
Placement Agent Warrants [Member]                      
Class of warrant or right, number of securities called by warrants or rights         127,346   127,346        
Class of warrant or right, exercise price of warrants or rights         $ 1.25   $ 1.25        
Private Placement [Member]                      
Class of warrant or right, number of securities called by warrants or rights         423,291   423,291        
Series B Preferred Stock [Member] | Private Placement [Member]                      
Class of warrant or right, number of securities called by warrants or rights         3,403,367   3,403,367        
Class of warrant or right, exercise price of warrants or rights         $ 1.05   $ 1.05     $ 1.25  
Class of warrant or right, expiration period             5 years     5 years  
Employees [Member]                      
Compensation expense         $ 74,005   $ 524,739        
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized         255,159   255,159        
Unamortized stock option expense         582,235   582,235        
Non-Employees [Member]                      
Compensation expense         65,061   326,028        
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized         327,076   $ 327,076        
Stock Option [Member]                      
Number of stock options granted             126,567 280,000      
Stock option weighted average exercise price per share             $ 1.00 $ 1.25      
Compensation expense         $ 139,066 $ 261,138 $ 711,701 $ 607,795      
Stock Options [Member]                      
Number of stock options granted 25,000 101,567                  
Stock option weighted average exercise price per share $ 1.75 $ 1.00                  
Stock options granted, term 10 years 10 years                  
Number of stock options vested   59,900                  
Stock options fair value $ 36,374 $ 199,807                  
Stock Options [Member] | Vest bi-Weekly Over Two Months [Member]                      
Number of stock options vested   41,667                  
The 2016 Plan [Member]                      
Number of additional shares grants for issuance     564,378 564,378              
Number of shares available for grant     1,128,756 1,128,756 3,739,867   3,739,867        
Share-based payment award, expiration period             10 years